A Recombinant Elastic Peptide Rescues Elasticity From a Self‐Assembled Dermal Sheet Model Treated With Ascorbic Acid
Experimental Dermatology · 2026
DOI: 10.1111/exd.70205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2026. Verfasst von Chloé Chave und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique, UMR5305 CNRS/Université Claude Bernard Lyon 1, Lyon, France. Hauptthemen laut MEDLINE: Ascorbic Acid, Skin, Artificial, Peptides. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Association Nationale de la Recherche et de la Technologie, Université Claude Bernard Lyon 1.
Abstract (Originalsprache)
The extracellular matrix (ECM) plays a pivotal role in determining the structure and function of the skin. Collagen and elastin, in particular, are responsible for providing tensile strength and elasticity, respectively. However, imbalances in the components of the extracellular matrix (ECM) during tissue engineering often result in the deterioration of the mechanical properties and physiological relevance of dermal substitutes, in part due to the detrimental effect of ascorbic acid (AA) on elastic fibre biosynthesis. The objective of this study is to investigate the potential of a synthetic elastic protein (SEP) to improve ECM remodelling and to restore the equilibrium between collagen and elastin in reconstructed dermal tissues. Primary fibroblasts monolayers were treated with increasing concentrations of SEP in the presence or not of AA without affecting cytotoxicity. Western blot and immunofluorescence analyses showed that in the presence of AA – which typically reduced elastin synthesis‐ SEP improved elastic fibre formation without affecting type I collagen assembly. Additionally, 3D dermal substitutes treated with SEP and AA were analysed at the ultrastructural scale showing a specific colocalization of SEP with fibrillin‐rich fibrils. Finally, dynamic mechanical analyses were conducted to measure mechanical properties of decellularized ECM. In the presence of SEP, we observed an increase of 46% and 40% of elastic and Young's moduli respectively. By restoring ECM integrity, SEP is emerging as a promising biomimetic tool for the development of 3D skin substitutes. Its application has the potential to improve the physiological relevance and therapeutic value of engineered skin tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique, UMR5305 CNRS/Université Claude Bernard Lyon 1, Lyon, France.
- Lucas Meyer Cosmetics by Clariant, Toulouse, France.
ORCID-Profile: Romain Debret
Förderung
- Association Nationale de la Recherche et de la Technologie
- Université Claude Bernard Lyon 1
Zitieren
APA
Chave, C., Guard, J., Massias, T., Berthier, A., Leignadier, J., Sohier, J., & Debret, R. (2026). A Recombinant Elastic Peptide Rescues Elasticity From a Self‐Assembled Dermal Sheet Model Treated With Ascorbic Acid. Experimental Dermatology. https://doi.org/10.1111/exd.70205
Vancouver
Chave C, Guard J, Massias T, Berthier A, Leignadier J, Sohier J, et al. A Recombinant Elastic Peptide Rescues Elasticity From a Self‐Assembled Dermal Sheet Model Treated With Ascorbic Acid. Experimental Dermatology. 2026. doi:10.1111/exd.70205
BibTeX
@article{Chave2026,
author = {Chave, Chloé and Guard, Jorgan and Massias, Thibault and Berthier, Aurore and Leignadier, Julie and Sohier, Jérôme and Debret, Romain},
title = {A Recombinant Elastic Peptide Rescues Elasticity From a Self‐Assembled Dermal Sheet Model Treated With Ascorbic Acid},
journal = {Experimental Dermatology},
year = {2026},
doi = {10.1111/exd.70205}
}
EUVIMED